1)Ssentongo P, et al : Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening : a systematic review and meta-analysis. JAMA Netw Open 4 : e2120736, 2021
2)国立研究開発法人日本医療研究開発機構(AMED)成育疾患克服等次世代育成基盤研究事業 母子感染に対する母子保健体制構築と医療開発技術のための研究班(平成28年度〜30年度):サイトメガロウイルス妊娠管理マニュアル(第2版).2018http://cmvtoxo.umin.jp/_assets/pdf/manual_cmv.pdf
3)Tanimura K, et al : Universal screening with use of immunoglobulin G avidity for congenital cytomegalovirus infection. Clin Infect Dis 65 : 1652-1658, 2017
4)Maltezou PG, et al : Maternal type of CMV infection and sequelae in infants with congenital CMV : systematic review and meta-analysis. J Clin Virol 129 : 104518, 2020
5)Uchida A, et al : Clinical factors associated with congenital cytomegalovirus infection : a cohort study of pregnant women and newborns. Clin Infect Dis 71 : 2833-2839, 2020
6)Imafuku H, et al : Clinical and ultrasound features associated with congenital cytomegalovirus infection as potential predictors for targeted newborn screening in high-risk pregnancies. Sci Rep 10 : 19706, 2020
7)Tanimura K, et al : Fetal ultrasound and magnetic resonance imaging abnormalities in congenital cytomegalovirus infection associated with and without fetal growth restriction. Diagnostics(Basel) 13 : 306, 2023
8)Haller T, et al : Should hearing targeted screening for congenital cytomegalovirus infection be implemented? Int J Pediatr Otorhi 134 : 110055, 2020
9)Fowler KB, et al : A targeted approach for congenital cytomegalovirus screening within newborn hearing screening. Pediatrics 139 : e20162128, 2017
10)Letamendia-Richard E, et al : Universal newborn screening for congenital cytomegalovirus infection : feasibility and relevance in a French type-III maternity cohort. BJOG 129 : 291-299, 2022
11)Kimberlin DW, et al : Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system : a randomized, controlled trial. J Pediatr 143 : 16-25, 2003
12)Kimberlin DW, et al : Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 372 : 933-943, 2015
13)Morioka I, et al : Efficacy and safety of valganciclovir in patients with symptomatic congenital cytomegalovirus disease : study protocol clinical trial(SPIRIT compliant). Medicine(Baltimore) 99 : e19765, 2020
14)国立研究開発法人日本医療研究開発機構(AMED)成育疾患克服等総合研究事業―BIRTHDAY サイトメガロウイルス,トキソプラズマ等の母子感染の予防と診療に関する研究班:サイトメガロウイルス,バルガンシクロビル治療の適正使用の手引き.2022 http : //cmvtoxo.umin.jp/cmv/09.html
15)Fernandez C, et al : Lower prevalence of congenital cytomegalovirus infection in Portugal : possible impact of COVID-19 lockdown? Eur J Pediatr 181 : 1259-1262, 2022
16)Revello MG, et al : A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 370 : 1316-1326, 2014
17)Devlieger R, et al : Serial monitoring and hyperimmunoglobulin versus standard of care to prevent congenital cytomegalovirus infection : a phase III randomized trial. Fetal Diagn Ther 48 : 611-623, 2021
18)Hughes BL, et al : A trial of hyperimmune globulin to prevent congenital cytomegalovirus infection. N Engl J Med 385 : 436-444, 2021
19)Shahar-Nissan K, et al : Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy : a randomised, double-blind, placebo-controlled trial. Lancet 396 : 779-785, 2020
20)Nigro G, et al : Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353 : 1350-1362, 2005
21)Japanese Congenital Cytomegalovirus Infection Immunoglobulin Fetal Therapy Study Group:A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection. J Reprod Immunol 95 : 73-79, 2012
22)Leruez-Ville M, et al : In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol 215 : 462.e1-462.e10, 2016
23)Tanimura K, et al : Immunoglobulin fetal therapy and neonatal therapy with antiviral drugs improve neurological outcome of infants with symptomatic congenital cytomegalovirus infection. J Reprod Immunol 143 : 103263, 2021